These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 26549923

  • 1. Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis.
    Chi S, Yu Y, Shi J, Zhang Y, Yang J, Yang L, Liu X.
    Dis Markers; 2015; 2015():450351. PubMed ID: 26549923
    [Abstract] [Full Text] [Related]

  • 2. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H, Ekblom-Kullberg S, Miettinen A.
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [Abstract] [Full Text] [Related]

  • 3. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
    Smykał-Jankowiak K, Niemir ZI, Polcyn-Adamczak M.
    Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
    [Abstract] [Full Text] [Related]

  • 4. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
    Emad G, Al-Barshomy SM.
    Saudi J Kidney Dis Transpl; 2020 Sep; 31(2):342-352. PubMed ID: 32394906
    [Abstract] [Full Text] [Related]

  • 5. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
    Kianmehr N, Khoshmirsafa M, Shekarabi M, Falak R, Haghighi A, Masoodian M, Seif F, Omidi F, Shirani F, Dadfar N.
    J Immunoassay Immunochem; 2021 Jul 04; 42(4):406-423. PubMed ID: 33788670
    [Abstract] [Full Text] [Related]

  • 6. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H.
    Arthritis Rheum; 2011 Aug 04; 63(8):2436-44. PubMed ID: 21506094
    [Abstract] [Full Text] [Related]

  • 7. [Correlation of anti-C1q antibodies with active systemic lupus erythematosus and lupus nephritis in children].
    Li YZ, Yang JR, Zhang YD, Cao Y, Li XY, Shuai LJ, Wang Y, Shen T, Wu XC.
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Aug 15; 26(8):835-839. PubMed ID: 39148388
    [Abstract] [Full Text] [Related]

  • 8. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 15; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 9. Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China.
    Zhang CQ, Ren L, Gao F, Mu FY, You YQ, Liu YH.
    Clin Rheumatol; 2011 Jul 15; 30(7):967-73. PubMed ID: 21340499
    [Abstract] [Full Text] [Related]

  • 10. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis.
    Elshweikh SA, Elkhouly RM, Shaalan MM, Shorbagy SH.
    Egypt J Immunol; 2014 Jul 15; 21(2):49-59. PubMed ID: 25812352
    [Abstract] [Full Text] [Related]

  • 11. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V, Stanković A, Cvetković T, Mitić B, Kostić S, Nedović J, Stamenković B.
    Srp Arh Celok Lek; 2014 Jul 15; 142(7-8):431-6. PubMed ID: 25233687
    [Abstract] [Full Text] [Related]

  • 12. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus.
    Gargiulo Mde L, Gómez G, Khoury M, Collado MV, Suárez L, Álvarez C, Sarano J.
    Medicina (B Aires); 2015 Jul 15; 75(1):23-8. PubMed ID: 25637896
    [Abstract] [Full Text] [Related]

  • 13. Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement.
    ElGendi SS, El-Sherif WT.
    Egypt J Immunol; 2009 Jul 15; 16(1):135-48. PubMed ID: 20726330
    [Abstract] [Full Text] [Related]

  • 14. Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis.
    Soliman AF, Egailla SE, Abdel-Gawad ER, Mansour AI, ElKhouly TH, Mahgoub MY.
    Egypt J Immunol; 2016 Jan 15; 23(1):107-116. PubMed ID: 28502158
    [Abstract] [Full Text] [Related]

  • 15. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X, Ren L, Sun G, Yu T, Yao Y, Wang L, Liu F, Zhang L, He X, Liu M.
    Immun Inflamm Dis; 2021 Jun 15; 9(2):407-418. PubMed ID: 33470559
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis.
    Yin Y, Wu X, Shan G, Zhang X.
    Lupus; 2012 Sep 15; 21(10):1088-97. PubMed ID: 22777943
    [Abstract] [Full Text] [Related]

  • 17. Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis.
    Fang QY, Yu F, Tan Y, Xu LX, Wu LH, Liu G, Shao FM, Zhao MH.
    Nephrol Dial Transplant; 2009 Jan 15; 24(1):172-8. PubMed ID: 18697800
    [Abstract] [Full Text] [Related]

  • 18. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Jan 15; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 19. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar 15; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 20. Cut-off values of immunological tests to identify patients at high risk of severe lupus nephritis.
    Gargiulo MLÁ, Khoury M, Gómez G, Grimaudo S, Suárez L, Collado MV, Sarano J.
    Medicina (B Aires); 2018 Mar 15; 78(5):329-335. PubMed ID: 30285925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.